Mark N. Tompkins - 27 Mar 2025 Form 4 Insider Report for Aeluma, Inc. (ALMU)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
31 Mar 2025, 19:07:43 UTC
Prior SEC filing
05 Nov 2024
Next SEC filing
14 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark N. Tompkins

Key filing fact

Mark N. Tompkins filed Form 4 for Aeluma, Inc. (ALMU) on 31 Mar 2025.

Key facts

  • This page summarizes Mark N. Tompkins's Form 4 filing for Aeluma, Inc. (ALMU).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 31 Mar 2025, 19:07.

Change

  • Previous filing in this sequence was filed on 05 Nov 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALMU transaction

Common Stock

Conversion of derivative security

Transaction value
$700,000
Shares
+200,000
Change %
+7.4%
Price
$3.50
Shares after
2,915,833
Date
27 Mar 2025
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALMU transaction Derivative

Convertible Promissory Note

Conversion of derivative security

Transaction value
$700,000
Shares
Change %
Price
Shares after
0
Date
27 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
200,000
Exercise price
$3.50
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On August 5 and August 27, 2024, the Reporting Person purchased from the Issuer, in a private placement exempt from registration under the Securities Act, $500,000 and $200,000, respectively, principal amount ($700,000 in the aggregate) of the Issuer's 0% convertible promissory notes with a maturity date of June 30, 2026. The form of the notes was filed with the Securities and Exchange Commission by the Issuer on August 6, 2024, as an exhibit to a Current Report on Form 8-K: https://www.sec.gov/Archives/edgar/data/1828805/000121390024065747/ea021072201ex10-2_aeluma.htm. The notes were convertible into shares of the Issuer's common stock only upon the occurrence of certain specified future events and at a price that was to be determined at the time of conversion(2)

Footnote F2

The conversion events included: (a) upon an equity financing resulting in gross proceeds to the Issuer of at least $5,000,000, the notes would convert at a price per share equal to 85% of the per share price paid by the investors in the financing; and (b) upon the Issuer's stock being accepted for listing on a national securities exchange or market, the notes would convert at a price per share equal to 85% of the volume weighted average price of the common stock for the five trading days immediately prior to the listing; provided that the conversion price would not be lower than a specified floor price nor higher than $3.50 per share. On March 27, 2025, as a result of the Issuer's public offering of shares of common stock at $5.25 per share for gross proceeds exceeding $5,000,000 and the listing of the common stock on the Nasdaq Capital Market, the notes converted in full at $3.50 per share into 200,000 shares of common stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .